Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gertz

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Genome Research|August 1, 2019
Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancerZannel Blanchard, Jeffery M Vahrenkamp, Kristofer C Berrett, et al.
Genome Research|August 4, 2005
Discovery, validation, and genetic dissection of transcription factor binding sites by comparative and functional genomicsJason Gertz, Linda Riles, Peter Turnbaugh, et al.
Epigenetics & Chromatin|November 28, 2013
Mapping genome-wide transcription factor binding sites in frozen tissuesDaniel Savic, Jason Gertz, Preti Jain, et al.
Molecular Endocrinology (Baltimore, Md.)|November 15, 2011
Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cellsNatalie E Simpson, Jason Gertz, Keren Imberg, et al.
Bioinformatics (Oxford, England)|November 5, 2003
Inferring protein interactions from phylogenetic distance matricesJason Gertz, Georgiy Elfond, Anna Shustrova, et al.
Molecular and Cellular Biology|July 18, 2012
The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genesTimothy E Reddy, Jason Gertz, Gregory E Crawford, et al.
Genome Research|September 29, 2012
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific mannerJason Gertz, Timothy E Reddy, Katherine E Varley, et al.
BMC Medicine|April 19, 2015
Improved survival among colon cancer patients with increased differentially expressed pathwaysMartha L Slattery, Jennifer S Herrick, Lila E Mullany, et al.
Life Science Alliance|October 2, 2019
Sufficiency analysis of estrogen responsive enhancers using synthetic activatorsMatthew Ginley-Hidinger, Julia B Carleton, Adriana C Rodriguez, et al.
Tissue Engineering. Part A|May 29, 2020
Synergistic CRISPRa-Regulated Chondrogenic Extracellular Matrix Deposition Without Exogenous Growth FactorsNiloofar Farhang, Bryton Davis, Jacob Weston, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Genome Research|August 1, 2019
Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancerZannel Blanchard, Jeffery M Vahrenkamp, Kristofer C Berrett, et al.
Genome Research|August 4, 2005
Discovery, validation, and genetic dissection of transcription factor binding sites by comparative and functional genomicsJason Gertz, Linda Riles, Peter Turnbaugh, et al.
Epigenetics & Chromatin|November 28, 2013
Mapping genome-wide transcription factor binding sites in frozen tissuesDaniel Savic, Jason Gertz, Preti Jain, et al.
Molecular Endocrinology (Baltimore, Md.)|November 15, 2011
Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cellsNatalie E Simpson, Jason Gertz, Keren Imberg, et al.
Bioinformatics (Oxford, England)|November 5, 2003
Inferring protein interactions from phylogenetic distance matricesJason Gertz, Georgiy Elfond, Anna Shustrova, et al.
Molecular and Cellular Biology|July 18, 2012
The hypersensitive glucocorticoid response specifically regulates period 1 and expression of circadian genesTimothy E Reddy, Jason Gertz, Gregory E Crawford, et al.
Genome Research|September 29, 2012
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific mannerJason Gertz, Timothy E Reddy, Katherine E Varley, et al.
BMC Medicine|April 19, 2015
Improved survival among colon cancer patients with increased differentially expressed pathwaysMartha L Slattery, Jennifer S Herrick, Lila E Mullany, et al.
Life Science Alliance|October 2, 2019
Sufficiency analysis of estrogen responsive enhancers using synthetic activatorsMatthew Ginley-Hidinger, Julia B Carleton, Adriana C Rodriguez, et al.
Tissue Engineering. Part A|May 29, 2020
Synergistic CRISPRa-Regulated Chondrogenic Extracellular Matrix Deposition Without Exogenous Growth FactorsNiloofar Farhang, Bryton Davis, Jacob Weston, et al.
Pageof 9